Repeated False-Positive HIV Test Results in a Patient Taking HIV Pre-Exposure Prophylaxis

被引：11

作者：

Stekler, Joanne D. ^{[1
,2
,3
]}

Violette, Lauren R. ^{[1
]}

Niemann, Lisa ^{[1
]}

McMahan, Vanessa M. ^{[1
]}

Katz, David A. ^{[1
,4
]}

Bamen, Jared M. ^{[1
,2
,3
]}

Grant, Robert M. ^{[5
]}

Delaney, Kevin P. ^{[6
]}

机构：

[1] Univ Washington, Dept Med, Seattle, WA USA

[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA

[4] Publ Hlth Seattle & King Cty, HIV STD Program, Washington, DC USA

[5] Univ Calif San Francisco, San Francisco, CA 94143 USA

[6] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2018年 / 5卷 / 09期

基金：

美国国家卫生研究院;

关键词：

PrEP; pre-exposure prophylaxis; HIV testing; seroconversion; false-positive; PERFORMANCE; PLASMA;

D O I：

10.1093/ofid/ofy197

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Regular HIV testing is required to ensure the safety of HIV pre-exposure prophylaxis (PrEP). We describe and discuss a series of false-positive HIV test results from an individual receiving PrEP. The expansion of PrEP will likely result in greater numbers of false-positive test results that may pose challenges for interpretation.

引用

页数：4

共 50 条

[41] The Relationship Between HIV Pre-exposure Prophylaxis Stigma and Treatment Adherence Among Current HIV Pre-exposure Prophylaxis Users in the Southeastern US
Van Gerwen, Olivia T.
Yigit, Ibrahim
Crockett, Kaylee B.
Turan, Bulent
AIDS AND BEHAVIOR, 2023, 27 (05) : 1478 - 1485
[42] Adherence and persistence of HIV pre-exposure prophylaxis use in the United States
McCormick, Carter D.
Sullivan, Patrick S.
Qato, Dima M.
Crawford, Stephanie Y.
Schumock, Glen T.
Lee, Todd A.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
[43] Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention
Van Epps, Puja
Wilson, Brigid M.
Garner, Will
Beste, Lauren A.
Maier, Marissa M.
Ohl, Michael E.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (05) : 427 - 430
[44] Configuring the users of new HIV-prevention technologies: the case of HIV pre-exposure prophylaxis
Holt, Martin
CULTURE HEALTH & SEXUALITY, 2015, 17 (04) : 428 - 439
[45] Willingness to Use HIV Pre-Exposure Prophylaxis Among Opiate Users
Stein, Michael
Thurmond, Portia
Bailey, Genie
AIDS AND BEHAVIOR, 2014, 18 (09) : 1694 - 1700
[46] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
Vanbaelen, Thibaut
Rotsaert, Anke
Jacobs, Bart K. M.
Florence, Eric
Kenyon, Chris
Vuylsteke, Bea
Laga, Marie
Thijs, Reyniers
AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
[47] Knowledge and perception of HIV pre-exposure prophylaxis among healthcare workers
Gil, Paula Knoch Mendonca
Conrado, Danilo dos Santos
do Nascimento, Ana Isabel
da Cunha, Joao Cesar Pereira
Koch, Gabriel Serrano Ramires
Maciel, Camila Guadeluppe
Santos-Pinto, Claudia Du Bocage
de Oliveira, Everton Falcao
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2025, 37 (05): : 780 - 789
[48] HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis
Volk, Jonathan E.
Dong Phuong Nguyen
Hare, C. Bradley
Marcus, Julia L.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (04) : 329 - 330
[49] HIV prevention trial design in an era of effective pre-exposure prophylaxis
Cutrell, Amy
Donnell, Deborah
Dunn, David T.
Glidden, David V.
Grobler, Anneke
Hanscom, Brett
Stancil, Britt S.
Meyer, R. Daniel
Wang, Ronnie
Cuffe, Robert L.
HIV CLINICAL TRIALS, 2017, 18 (5-6): : 177 - 188
[50] HIV False-Positive Test in the Setting of CD4 Lymphocytopenia
Mohamed, Hussien
Hedriana, Hanna D.
Holbrook, Emily A.
Henderson, Heather
Wilson, Jason W.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)

← 1 2 3 4 5 →